← Open Payments lookup

DANIEL DAMITIO: Open Payments

NPI 1982180386 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$254 in 9 payments from 4 companies in 2025. Trend: 2023 $273 · 2024 $308 · 2025 $254

Food & beverage: $254
CompanyPaymentsAmount
Gilead Sciences, Inc.5$101
GlaxoSmithKline, LLC.1$95
AstraZeneca Pharmaceuticals LP2$35
ABBVIE INC.1$23

Products named: AREXVY, VRAYLAR, BREZTRI, FARXIGA.

Industry payments across MS — which companies pay providers there.